Aug 20 (Reuters) - Swiss-American eye-care group Alcon

on Tuesday cut its 2025 net sales outlook, saying it

expects the impact of U.S. tariffs to persist through the

remainder of the year.

Alcon, which makes nearly half of its revenue in the U.S.,

lowered its projected net sales range to $10.3 to $10.4 billion

from $10.4 to $10.5 billion forecasted in May.

It now forecasts a full-year gross tariff impact around $100

million but expects to offset that through operational changes

and foreign exchange movements.

The U.S. tariff rate of 39% on goods from Switzerland is

higher than nearly any other Western trading partner.

In 2024 46% of Alcon's net sales were made in the U.S.

The Swiss-American group posted a 4% rise in its

second-quarter sales to $2.58 billion, missing analysts' average

forecast of $2.63 billion, according to LSEG data. It said

demand for its surgical products was relatively weak in the

first half.

Alcon shares were down 8.25% in Julius Baer pre-market

indications as at 0620 GMT.